CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Colostrum bovine +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06123910
NCT06123910N/ACompleted

Effect of Bovine Colostrum Supplementation on Neutrophil Function in Recreational Athletes

Centro de Investigación en Alimentación y Desarrollo A.C.·interventional·Posted Nov 9, 2023·Updated Nov 9, 2023

In Brief

A clinical study evaluating Colostrum bovine and Placebo for Innate Immunity. Completed, enrolled 32 participants across 1 site.

Detailed Summary

32 recreational athletes who will attend to the Grand Marathon in the nort west of Mexico, event that will be held on December 2, 2018 or 21k Trail to be held in April 2019 will be invited to the study. Participants will be informed about the study procedures through a consent informed. Participants will be randomly divided into two groups, 16 in the intervention group and 16 in the comparison group. The participants will be recreational athletes between 18 and 60 years old. They must have athletic experience of at least 3 years. The participants considered will be those who perform vigorous physical activity per week according to the criteria of the short version IPAQ instrument. Smoking subjects with food intolerances and allergies, cardiovascular history will be excluded. Patients who have had a respiratory infection symptom in the last two weeks will not be able to participate in the study. Participants who are consuming some type of food supplement will be excluded. Two 18 ml of blood samples will be taken from the vein of the forearm by venipuncture of each participant, using K2EDTA tubes after and before supplementation period. Blood samples were taken before a corporal, aerobic and nutritional evaluations. CB supplementation will begin 4 weeks prior to competition events. One group will consume 20 g of bovine colostrum daily in solution with water. The second group will consume a placebo product with a nutritional composition similar to the group with the treatment of bovine colostrum. Both groups should take the supplement before breakfast with empty stomach.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInnate Immunity
CountriesMexico
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 9, 2023
Enrollment StartOct 10, 2018
Primary CompletionNov 13, 2018
Study CompletionApr 5, 2019
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 2.6 years ago

Interventions

Colostrum bovinedietary

Colostrum bovine supplements, 25 kcal per portion, containing 0.25 g fats, 2.0 g CHO and 3 g protein. Lactose reduced.

Placeboother

Dairy comercial product. 25 kcal per portion, 1.3 g fats, 1.95 CHO and 1.3 protein. Lactose based.